Choe K, Ali M, Lardenoije R, Riemens RJM, Pishva E, Bickel H, Weyerer S, Hoffmann P, Pentzek M, Riedel-Heller S, Wiese B, Scherer M, Wagner M, Mastroeni D, Coleman PD, Ramirez A, Ramakers IH, Verhey FR, Rutten BPF, Kenis G, van den Hove DLA. Alzheimer's disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway. Alzheimers Res Ther. 2024 16(1):259.
Kleineidam L, Oezdemir S, Martino-Adami P, Chatterjee M, Pentzek M, Weyerer S, Bickel H, Wiese B, Riedel-Heller SG, Scherer M, Zetterberg H, Blennow K, Jeromin A, Wagner M, Ramirez A, Schneider A. Biomarkers. Alzheimers Dement. 2024 20 Suppl 2:e092239.
Kraake S, Pabst A, Bickel H, Pentzek M, Fuchs A, Wiese B, Oey A, König H, Brettschneider C, Scherer M, Mallon T, Lühmann D, Maier W, Wagner M, Heser K, Weyerer S, Werle J, Riedel-Heller SG, Stein J. Profiles of met and unmet care needs in the oldest-old primary care patients with cognitive disorders and dementia - results of the AgeCoDe and AgeQualiDe study. Dement Geriatr Cogn Disord. 2024 54(2):69-84. Epub 2025 Aug 29.
Kraake S, Pabst A, Wiese B, Moor L, König H, Hajek A, Kaduszkiewicz H, Scherer M, Stark A, Wagner M, Maier W, Werle J, Weyerer S, Riedel-Heller SG, Stein J. Profiles of met and unmet care needs in the oldest-old primary care patients with depression - results of the AgeMooDe study. J Affect Disord. 2024 350:618-626. Epub 2024 Jan 19.
Liegert P, Pabst A, Conrad I, van den Bussche H, Eisele M, Hajek A, Heser K, Kleineidam L, Weyerer S, Werle J, Pentzek M, Weeg D, Mösch E, Wiese B, Oey A, Wagner M, Maier W, König H, Riedel-Heller SG, Scherer M, Luppa M. The effect of depressive symptoms on quality of life and its different facets in the oldest age population: evidence from the AgeQualiDe prospective cohort study. Qual Life Res. 2024 33(2):387-398. Epub 2023 Oct 28.
Luppa M, Pabst A, Löbner M, Mallon T, Brettschneider C, Hajek A, Heser K, Kleineidam L, Weyerer S, Werle J, Pentzek M, Weeg D, Mösch E, Wiese B, Oey A, Wagner M, Maier W, Scherer M, König H, Riedel-Heller SG. Age-specific risk factors of depression among the oldest-old - evidence from the multicenter AgeCoDe-AgeQualiDe study. Front Psychiatry. 2024 15:1367225.
Martino-Adami PV, Chatterjee M, Kleineidam L, Weyerer S, Bickel H, Wiese B, Riedel-Heller SG, Scherer M, Blennow K, Zetterberg H, Wagner M, Schneider A, Ramirez A. Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study. Lancet Reg Health Eur. 2024 45:101030.
Moormann KI, Pabst A, Bleck F, Löbner M, Kaduszkiewicz H, van der Leeden C, Hajek A, Brettschneider C, Heser K, Kleineidam L, Werle J, Fuchs A, Weeg D, Bickel H, Pentzek M, Weyerer S, Wiese B, Wagner M, Maier W, Scherer M, König H, Riedel-Heller SG. Social isolation in the oldest-old: determinants and the differential role of family and friends. Soc Psychiatry Psychiatr Epidemiol. 2024 59(6):979-988. Epub 2023 Jul 5.
Oluwagbemigun K, Anesi A, Vrhovsek U, Mattivi F, Martino Adami P, Pentzek M, Scherer M, Riedel-Heller SG, Weyerer S, Bickel H, Wiese B, Schmid M, Cryan JF, Ramirez A, Wagner M, Nöthlings U. An Investigation into the Relationship of Circulating Gut Microbiome Molecules and Inflammatory Markers with the Risk of Incident Dementia in Later Life. Mol Neurobiol. 2024 61(12):9776-9793. Epub 2023 Aug 22.
Wehling M, Weindrich J, Weiss C, Heser K, Pabst A, Luppa M, Bickel H, Weyerer S, Pentzek M, König H, Lühmann D, van der Leeden C, Scherer M, Riedel-Heller SG, Wagner M, Pazan F. Validation of MyFORTA: An Automated Tool to Improve Medications in Older People Based on the FORTA List. Drugs Aging. 2024 41(6):555-564. Epub 2024 Jun 7.